Neurothekeoma in the Axilla Causing Persistent Shoulder Pain: Case Report^*

Abstract

Neurothekeomas, also known as neural sheath myxomas, are rare benign tumors of the neural sheath affecting most commonly the head, arms and shoulder of women in their 2^nd and 3^rd decades of life. Due to the low prevalence and undefined clinical picture, they are hardly considered in the initial differential diagnosis of skin tumors. We report the case of a 24 year-old woman who was seen in 2016 reporting > 1 year of moderate pain and limited mobility of her left shoulder. Clinical evaluation revealed restricted mobility of the affected shoulder and nuclear magnetic resonance imaging showed a T2-weighted contrast-enhanced multilobular mass in the quadrilateral area apparently invading the adjacent humeral cortical region. Histopathology of a needle sample material revealed loose fibroconnective tissue with no signs of invasion, mitosis or atypical figures. Successful surgical excision was performed and the diagnosis of neurothekeoma was confirmed after detailed histopathology, including immunohistochemistry. The patient was asymptomatic at 18 months of follow-up, with full recovery of shoulder movement and no signs of relapse.

Keywords
neurothekeoma; shoulder; tumors

Resumo

Neurotecomas, também conhecidos como mixomas da bainha neural, são tumores benignos raros da bainha neural afetando mais comumente a cabeça, braços e ombros de mulheres entre 20 e 40 anos de idade. Devido à baixa prevalência e quadro clínico mal definido, essas lesões são raramente consideradas no diagnóstico diferencial de tumores cutâneos. Relatamos o caso de uma mulher de 24 anos de idade que procurou atendimento em 2016 relatando dor moderada por mais de um ano e limitação dos movimentos do ombro esquerdo. Ao exame, foi constatada restrição da mobilidade dessa articulação e uma ressonância magnética revelou imagem multilobular com aumento de sinal em T2 na região quadrilateral, aparentando invasão da região cortical do úmero subjacente. A histopatologia de uma biópsia incisional mostrou lesão composta por tecido conjuntivo frouxo, sem sinais de invasão, figuras de mitose ou atipias. Foi realizada excisão completa da lesão e o diagnóstico de neurotecoma foi confirmado após análise histopatológica que incluiu painel imunohistoquímico. À revisão de 18 meses, a paciente estava assintomática com recuperação completa do movimento e sem evidência de recidiva da lesão.

Palavras-chave
neurotecoma; ombro; tumor

Introduction

Neurothekeoma is a rare benign skin tumor of the neural sheath, also known as neural sheath myxoma. It originates from the endoneurium of peripheral nerves and is characterized by abundant mucoid matrix. The rarity and noninvasive character of neurothekeomas probably account for them not being remembered as a diagnostic possibility, which led us to prepare the present case report.¹ Usually, neurothekeomas appear as solitary fibroelastic nodules on the skin localized in the head and neck regions and in the upper extremities.^1,2

Case Report

A 24 year-old woman sought specialized care on August 2016 for pain and restricted mobility of her left shoulder during the previous year. There was no history of repetitive use or isolated trauma, as well as no systemic manifestations. Pain was escalating in intensity in the last 2 months. Family history was negative and there were no comorbidities. She was using analgesics on demand. Physical and neurological examination revealed a mild restriction of external rotation of the left shoulder reaching up to 60° in active motion. Rotator cuff tests as well as neurovascular exam of the affected shoulder were normal. Shoulder radiographies were normal (Fig. 1) whereas magnetic resonance imaging (MRI) of the left shoulder revealed a T2-weighted contrast-enhanced nonspecific solid lobular lesion (3.3 × 2.6 × 1.7 cm) in the quadrilateral area close to the adjacent humeral cortical region (Fig. 2). A bone scintigraphy scan was negative.

Fig. 1
Presurgical radiological shoulder, anteroposterior (A) and left scapula profile (B) images.

Fig. 2
T2-weighted Nuclear Resonance Imaging, sagittal (A), coronal oblique (B), and axial (C) fat-suppressed MRI images of the left shoulder showing a large lobular mass with internal septations, well-defined contours, near the proximal humeral diaphysis, with no signs of invasion.

An incisional biopsy was inconclusive, and the apparent invasive characteristic seen in the MRI prompted surgical planning for complete excision. The histopathological analysis description after hematoxylin-eosin (H&E) staining revealed fusiform-shaped cells in a storiform arrangement with no atypia, forming nodules interspersed within a collagen stroma in a plexiform appearance together with some epithelioid foci, rendering definition of the histogenesis impossible (Fig. 3).

Fig. 3
Histologic appearance of the surgically excised mass. There is predominance of fusiform (arrow) and scattered epithelioid (arrowhead) cells with no signs of atypia or mitotic figures (H&E staining; Original x100).

The immunohistochemistry panel was positive for the S100 protein and epithelial membrane antigen (EMA) staining in areas of the proliferating fusiform cells, along with CD68 and smooth muscle actin (SMA) staining. The cell proliferative index, evaluated by K_i-67 marker staining, was < 1%.

The analysis of clinical and imaging data coupled to the histopathological evaluation led to the conclusion of a neurothekeoma diagnosis.

The surgical planning was for total mass excision, performed in April 2017, rendering the patient asymptomatic with no limitation of shoulder movement after 18 months follow-up. An MRI postsurgical exam showed no signs of relapse (Fig. 4).

Fig. 4
Postsurgical (18 months) T2-weighted coronal MRI view of the left shoulder.

Histopathology

Briefly, histopathological examination was performed on routinely prepared resected samples after paraffin-embedding with 4-µm sections stained with H&E. Immunohistochemistry was performed using a Ventana Benchmark apparatus (Ventana Medical Systems; Tucson, AZ, USA) after deparaffinization with EZprepbuffer (Ventana Medical Systems, Tucson, AZ, USA) (04 minutes). Antigen recovery was done with Cell Conditioning (Ventana Medical Systems, Tucson, AZ, USA) buffer (30 minutes; pH 8.4) followed by washings with the reaction buffer and amplification using UltraView, Hematoxylin and Bluing reagents (Ventana Medical Systems, Tucson, AZ, USA). Commercially available primary antibodies were as follows: S100 (Clone S1/61/69 1:1000; Leica Biosystems, Buffalo Grove, IL, USA), EMA (E29 1:5000; CellMarque Darmstadt, Germany), CD34 (QBEnd/10 Ready-to-use; Roche, São Paulo, SP, Brazil), CD68 (514h12 Ready-to-use; Roche, São Paulo, SP, Brazil), SMA (1A4 1:5000; CellMarque, Darmstadt, Germany) and KI67 (SP6 1:300 CellMarque, Darmstadt, Germany).

Discussion

Neurothekeomas are typically restricted to the skin and subcutaneous tissue, with lesions involving the axillary hollow being extremely unusual. Up to 35% of neurothekeomas are localized in the upper extremities.² The age range includes 15 month-old children as well as elderly up to 84 years old, with an 18 years old mean age incidence. Usually, the diameter of the lesions measures 1.2 cm. Local trauma and estrogen use have been proposed as trigger factors, probably because of the predominance in females1.^1,2

The histological appearance can be classified as myxoid, cellular, and mixed, based on cell predominance, presence of mucinous material, and abundance of myxoid matrix. Features to distinguish neurothekeomas from neural sheath myxomas are yet to be established.^3,4 Immunohistochemistry markers may help discriminate neurothekeoma subtypes, as follows: S100 protein, glial acidic fibrillary Protein (GFAP), nerve growth factor receptor, and melanoma-specific antigens (NKI/C3, K_i-M1p). The S100 A6 protein staining is highly positive in the cellular subtype. Histologically, neurothekeomas should be discriminated from other fibrohistiocytic tumors such as fibromyxomas.^4-6

Benign tumors are amenable to surgery when localized in areas that restrict movement and/or cause other functional limitation. The pain and limitation of movement in this case justified surgical excision. Lesions > 6 cm, involving the subcutaneous tissue, muscles and blood vessels, with pleomorphic cytological appearance, are considered atypical neurothekeomas. Marginal infiltration and high mitotic index (>3 perhpf) have been associated with the atypical subtype. In a series of 10 patients classified as presenting the atypical pattern followed for 5 years there were no local relapses or metastasis leading the authors to suggest that apparent histological aggressive behavior is not associated to the clinical outcome.^7,8

Neurothekeomas are rarely suspected prior to histopathology. There are no reports of malignant transformation or metastasis, but local recurrence, though uncommon, may happen, particularly in those presenting the cellular and mixed patterns. Complete surgical resection with clear margins, usually of some millimeters, is the appropriate treatment. Apparently, aggressive lesions have been subjected to resection with larger margins. Proposed risk factors for neurothekeoma relapse include: myxoid subtype, female gender, head localization, young age, compromised margins and absence of adipose tissue in the excised material. Presence of atypical cells and number of mitotic figures were not associated with recurrence.¹

Despite being rare, neurothekeomas need to be remembered as a diagnostic possibility when lesions involve the head and neck, since early surgical removal is usually curative.

The rare occurrence in the axillary hollow justifies the present case report coupled to the clinical picture in a young patient with a normal radiography prompting MRI request. Diagnostic delay can be caused by confounding with more frequent causes of a painful shoulder, such as rotator cuff lesion and adhesive capsulitis. The surgical planning contributed to a successful, curative intervention, with virtually no sequelae.

• *
  Study developed at the Orthopedics Service of the Hospital Geral de Fortaleza, Fortaleza, CE, Brazil.

Acknowledgment

We thank the laboratory Argos Patologia Clínica, Fortaleza, Brazil, 60175–047, for histological processing.

References

• ¹
  Fetsch JF, LaskinWB, Hallman JR, Lupton GP,Miettinen M. Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information. Am J Surg Pathol 2007;31(07):1103-1114
• ²
  Hornick JL, Fletcher CD. Cellular neurothekeoma: detailed characterizationina series of133cases.AmJ SurgPathol 2007;31(03):329-340
• ³
  Stratton J, Billings SD. Cellular neurothekeoma: analysis of 37 cases emphasizing atypical histologic features. Mod Pathol 2014; 27(05):701-710
• ⁴
  Fetsch JF, Laskin WB, Miettinen M. Nerve sheath myxoma: a clinicopathologic and immunohistochemical analysis of 57 morphologically distinctive, S-100 protein- and GFAP-positive, myxoid peripheral nerve sheath tumors with a predilection for the extremities and a high local recurrence rate. Am J SurgPathol 2005;29(12):1615-1624
• ⁵
  Plaza JA, Torres-Cabala C, Evans H, Diwan AH, Prieto VG. Immunohistochemical expression of S100A6 in cellular neurothekeoma: clinicopathologic and immunohistochemical analysis of 31 cases. Am J Dermatopathol 2009;31(05):419-422
• ⁶
  Sheth S, Li X, Binder S, Dry SM. Differential gene expression. profiles of neurothekeomas and nerve sheathmyxomas bymicroarray analysis. Mod Pathol 2011;24(03):343-354
• ⁷
  Campanati A, Brandozzi G, Sisti S, Bernardini ML, Offidani AM. Atypical neurothekeoma: a new case and review of the literature. J CutanPathol 2007;34(05):435-437
• ⁸
  Busam KJ,Mentzel T, Colpaert C, Barnhill RL, Fletcher CD. Atypical or worrisome features in cellular neurothekeoma: a study of 10 cases. Am J SurgPathol 1998;22(09):1067-1072

Publication Dates

• Publication in this collection
  03 Feb 2021
• Date of issue
  Nov-Dec 2020

History

• Received
  23 Oct 2019
• Accepted
  02 Mar 2020